News
Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...
Shares of GSK PLC GSK inched up 0.96% to £15.23 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.13% to 8,864.35. GSK ...
The release of Pretty Hurts comes two years after GSK collaborated with Lifetime on a short film highlighting the risks ...
Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...
1don MSN
By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...
Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...
After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...
'We are in a good spot': Gilead's new chief medical officer is committed to pipeline diversification
Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...
The benefits of 52-week biologic therapy on asthma control and lung function are observed in both never smokers and ...
FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.
5d
Zacks Investment Research on MSNHere's Why GSK (GSK) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Sublime’s award is just one of the 24 that were rolled back after U.S. Secretary of Energy Chris Wright announced the awards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results